Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

NCT03293030 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03293030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03293030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
October 22, 2018
Completion date
February 23, 2023
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, atopic dermatitis and related conditions, atopic dermatitis eczema, eczema